Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering
December 20, 2024
Biotechnology
-
-
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
December 20, 2024
-
INOVIO Announces Pricing of $30 Million Public Offering
December 13, 2024
-
Lumos Pharma and Double Point Ventures Announce Successful Completion of Tender Offer and Double Point Ventures’ Acquisition of Lumos Pharma
December 12, 2024
-
Sequire Spotlight Presents: BioHarvest Sciences (BHST) – Global Leader in Plant Cell Technology
December 3, 2024
-
Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply
December 3, 2024
-
Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren’s Syndrome Drug
December 2, 2024
-
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
November 27, 2024
-
Greenwich LifeSciences Partners with GIM in Italy
November 26, 2024
-
Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic
November 21, 2024
-
Sequire Spotlight Presents: Biostem (BSEM) – Harnessing the Natural Properties of Placenta Tissues
November 20, 2024
-
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer
November 20, 2024
-
Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC
November 19, 2024
-
Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger
November 11, 2024
-
Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
November 11, 2024
-
Ocugen Secures $30 Million in Debt Funding
November 7, 2024